Published in J Med Chem on November 25, 1994
Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis (1989) 5.88
Gas-liquid chromatographic determination of theophylline in human plasma. J Chromatogr (1975) 1.54
Limitations of the clonal agar assay for the assessment of primary human ovarian tumour biopsies. Br J Cancer (1982) 1.10
Nitric oxide synthesis in the CNS endothelium and macrophages differs in its sensitivity to inhibition by arginine analogues. Life Sci (1991) 1.05
MDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease. J Neural Transm Park Dis Dement Sect (1989) 0.99
Molecular design and modeling of protein-heparin interactions. Methods Enzymol (1991) 0.98
Activity of 5,7-dichlorokynurenic acid, a potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site. Mol Pharmacol (1990) 0.98
(S)-(-)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine maleate (SIB-1508Y): a novel anti-parkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors. J Med Chem (1996) 0.90
Inactivation of ribonucleotide reductase by (E)-2'-fluoromethylene-2'-deoxycytidine 5'-diphosphate: a paradigm for nucleotide mechanism-based inhibitors. Biochemistry (1996) 0.90
Characterization of cell selectivity of two novel inhibitors of nitric oxide synthesis. Eur J Pharmacol (1992) 0.90
A novel synthesis of xanthines: support for a new binding mode for xanthines with respect to adenosine at adenosine receptors. J Med Chem (1990) 0.89
Enzyme-activated irreversible inhibition of rat and mouse brain 4-aminobutyric acid-alpha-ketoglutarate transaminase by 5-fluoro-4-oxo-pentanoic acid. Biochem Biophys Res Commun (1982) 0.86
MDL 72145, an enzyme-activated irreversible inhibitor with selectivity for monoamine oxidase type B. J Neurochem (1984) 0.84
Enzyme-activated irreversible inhibitors of monoamine oxidase: phenylallylamine structure-activity relationships. J Med Chem (1985) 0.84
Conformational analysis of the endogenous mu-opioid agonist endomorphin-1 using NMR spectroscopy and molecular modeling. FEBS Lett (1998) 0.83
Inhibition of monoamine oxidase selectively in brain monoamine nerves using the bioprecursor (E)-beta-fluoromethylene-m-tyrosine (MDL 72394), a substrate for aromatic L-amino acid decarboxylase. J Neurochem (1985) 0.83
Conformation-reactivity relationship for pyridoxal Schiff's bases. Rates of racemization and alpha-hydrogen exchange of the pyridoxal Schiff's bases of amino acids. Biochemistry (1978) 0.82
Synthesis and evaluation of 4-(N,N-diarylamino)piperidines with high selectivity to the delta-opioid receptor: a combined 3D-QSAR and ligand docking study. Drug Des Discov (2000) 0.81
Resin activation capture technology: libraries from stabilized acyl-pyridinium on solid support. Biotechnol Bioeng (2000) 0.80
Haloallylamine inhibitors of MAO and SSAO and their therapeutic potential. J Neural Transm Suppl (1994) 0.80
Synthesis of acyclonucleoside hydroxamic acids as inhibitors of ribonucleotide reductase. J Med Chem (1989) 0.79
3-(2-carboxyindol-3-yl)propionic acid derivatives: antagonists of the strychnine-insensitive glycine receptor associated with the N-methyl-D-aspartate receptor complex. J Med Chem (1990) 0.79
3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding site. J Med Chem (1992) 0.79
4-[[2-(1-Methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A): a novel cognitive enhancer with selectivity for neuronal nicotinic acetylcholine receptors. J Med Chem (1999) 0.79
Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site. J Pharmacol Exp Ther (1992) 0.78
Inhibition of rat aorta semicarbazide-sensitive amine oxidase by 2-phenyl-3-haloallylamines and related compounds. Biochem Pharmacol (1987) 0.78
Design and early clinical evaluation of selective inhibitors of monoamine oxidase. Prog Neuropsychopharmacol Biol Psychiatry (1988) 0.77
MDL 72,974A: a selective MAO-B inhibitor with potential for treatment of Parkinson's disease. J Neural Transm Suppl (1993) 0.77
Recombinant human receptors and functional assays in the discovery of altinicline (SIB-1508Y), a novel acetylcholine-gated ion channel (nAChR) agonist. Pharm Acta Helv (2000) 0.77
(E)-2-(3,4-dimethoxyphenyl)-3-fluoroallylamine: a selective, enzyme-activated inhibitor of type B monoamine oxidase. J Med Chem (1984) 0.77
Enzyme-activated antagonists of the strychnine-insensitive glycine/NMDA receptor. J Med Chem (1994) 0.77
The rational design of suicide substrates of amine oxidases. Biochem Soc Trans (1986) 0.76
Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist. J Pharmacol Exp Ther (1997) 0.76
Electronic record linkage to create diabetes registers. Impressive results can be obtained without record linkage. BMJ (1998) 0.75
(Z)-2-(2,4-Dichlorophenoxy)methyl-3-fluoroallylamine (MDL 72638): a clorgyline analogue with surprising selectivity for monoamine oxidase type B. Biochem Pharmacol (1986) 0.75
4-[(Carboxymethyl)oxy]- and 4-[(carboxymethyl)amino]-5,7-dichloroquinoline-2-carboxylic acid: new antagonists of the strychnine-insensitive glycine binding site on the N-methyl-D-aspartate receptor complex. J Med Chem (1990) 0.75
Dermahesive: a new concept in surgical dressings. Med J Aust (1977) 0.75
Naegele's pelvis. Med J Aust (1966) 0.75
Conformational analysis of some phenethylamine molecules. J Theor Biol (1973) 0.75
Depletion of estrogen receptor in human breast tumor cells by a novel substituted indole that does not bind to the hormone binding domain. J Steroid Biochem Mol Biol (1996) 0.75
Effect of GABA and isogabaculine on ornithine decarboxylase and putrescine metabolism. Am J Physiol (1982) 0.75
Planned pregnancy in a patient who was receiving home parenteral nutrition. Med J Aust (1987) 0.75
Chromosome damage and sister chromatid exchanges in lymphocyte cultures from patients with two primary cancers. Cancer Genet Cytogenet (1985) 0.75
Electroejaculation of the paraplegic male followed by pregnancy. Med J Aust (1975) 0.75
Conformational energy differences between side chain alkylated analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane. J Med Chem (1980) 0.75
Single dose tinidazole prophylaxis in hysterectomy. Aust N Z J Obstet Gynaecol (1985) 0.75
1-(Thienylalkyl)imidazole-2(3H)-thiones as potent competitive inhibitors of dopamine beta-hydroxylase. J Med Chem (1990) 0.75
New directions in anxiolytic drug research. Prog Med Chem (1999) 0.75
On the tertiary structure of tropomysin tactoids. Biochem Biophys Res Commun (1975) 0.75
Conformational analysis of pyridoxal Schiff's bases. Nuclear magnetic resonance studies of the conformations about the C4-C4', Calpha-Cbeta, and N-Calpha bonds of the pyridoxal Schiff's bases of amino acids. Biochemistry (1978) 0.75
The use of rigid analogues to probe hallucinogen receptors. NIDA Res Monogr (1978) 0.75
The local minima method (LMM) of pharmacophore determination: a protocol for predicting the bioactive conformation of small, conformationally flexible molecules. J Chem Inf Comput Sci (1999) 0.75
Secondary haemorrhage from the ovarian blood vessels--a case report. Aust N Z J Obstet Gynaecol (1965) 0.75
Extraction procedures for some common drugs in clinical and forensic toxicology. J Forensic Sci (1976) 0.75
(R)-4-oxo-5-phosphononorvaline: a new competitive glutamate antagonist at the NMDA receptor complex. J Med Chem (1990) 0.75
Incompetence of the cervix. Aust N Z J Obstet Gynaecol (1978) 0.75
Conformationally restricted analogues of nicotine and anabasine. Bioorg Med Chem Lett (1998) 0.75
Modeling of competitive phosphono amino acid NMDA receptor antagonists. J Med Chem (1992) 0.75
Cervical cerclage. Clin Obstet Gynaecol (1980) 0.75
John Kenneth Gabriel. Med J Aust (1977) 0.75
A view of education in obstetrics and gynecology. Med J Aust (1969) 0.75
Inhibition of steroid C17(20) lyase with C-17-heteroaryl steroids. Bioorg Med Chem (1996) 0.75